Therefore, it is important to elucidate the mechanisms by which the pathway regulates p21CIP1 expression and how p21CIP1 expression is suppressed in tumor cells that exhibit aberrant MEK/ERK activity. This evidence concerns the gene MAP2K7 and neoplasm.